Cowealth Medical Soars 9.99% to Day High Amid Market Decline

Cowealth Medical China Co., Ltd. has experienced significant activity today, with the stock rising by 9.99% as of June 23, 2026. The stock reached an intraday high of CNY 12.77, marking a notable performance against the backdrop of the China Shanghai Composite, which declined by 1.37% on the same day. In terms of performance metrics, Cowealth Medical has shown a 5.19% increase over the past week, while its one-year performance stands impressively at 95.86%, significantly outperforming the Shanghai Composite's 21.43% gain. However, the stock has faced challenges in the longer term, with a year-to-date decline of 47.66%. Despite the recent uptick, the company has reported negative financial results over the last nine consecutive quarters, with a pre-tax profit of CNY -5.44 million and a net profit of CNY -5.05 million. The company operates within the Pharmaceuticals & Biotechnology sector and has a market capitalization of CNY 2,174 million. As a small-cap entity, Cowealth Medical's financial metrics, including a return on equity of -3.43% and a debt-to-equity ratio of 0.08, indicate a complex financial landscape.